TP53 and breast cancer: The pooled OR in 3 studies with 713 BC patients also indicated a strong relationship between elevated PLK1 expression and p53 mutation status (OR = 6.663, 95% CIs: 4.249-10.448, P < 0.001, Figure 2f).